FrederickBarrettMD
Pediatric Infectious Disease • Memphis, TNInstructor of Psychiatry and Behavioral Sciences
Are you Dr. Barrett?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 5 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1910 Nonconnah Blvd
Suite 120
Memphis, TN 38132Phone+1 901-448-2300Fax+1 901-448-6657- Is this information wrong?
Summary
- Dr. Frederick Barrett, MD is a pediatric infectious disease specialist in Memphis, Tennessee.
Education & Training
Children's Hospital/Boston Medical Center Program AFellowship, Pediatric Infectious Diseases, 1966 - 1968
Baylor College of Medicine (Houston)Residency, Pediatrics, 1964 - 1965- Baylor College of MedicineClass of 1961
Certifications & Licensure
- American Board of Pediatrics Pediatrics
Clinical Trials
- Persisting Effects of Psilocybin Start of enrollment: 2017 Jul 01
- Effects of Salvinorin A on Brain Function Start of enrollment: 2017 Dec 14
Publications & Presentations
PubMed
- 44 citationsDouble-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognitionFrederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz, Matthew W. Johnson, Roland R. Griffiths> ;Psychopharmacology. 2018 Jul 30
- 60 citationsAn outbreak of aspergillosis in children with acute leukemiaDonald H. Mahoney, C. Philip Steuber, Kenneth A. Starling, Fred F. Barrett, Jacobo Goldberg, Donald J. Fernbach> ;The Journal of Pediatrics. 1979 Jul 1
- 27 citationsA fatal x-linked recessive reticuloendothelial syndrome with hyperglobulinemia. X-linked recessive reticuloendotheliosis.John M. Falletta, Donald J. Fernbach, Mary Ann South, Benjamin H. Landing, Clark W. Heath, Nomie A. Shore, Fred F. Barrett> ;The Journal of Pediatrics. 1973 Oct 1
- Join now to see all
Press Mentions
- How Psilocybin, the Psychedelic in Mushrooms, May Rewire the Brain to Ease Depression, Anxiety and MoreJune 11th, 2022
- PharmaDrug Announces Clinical Research Collaboration with the Johns Hopkins University to Evaluate DMT in a Comparative Clinical StudyAugust 25th, 2021
- PharmaDrug Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate DMT in a Comparative Clinical StudyAugust 25th, 2021
- Join now to see all
